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Background: Obesity is a significant risk factor for hypertension and diabetes. A cohort of 50-year-old voluntary
periodic health examination (PHE) participants was analyzed 15 years retrospectively. Our aim was to evaluate
changes in body mass index (BMI) and blood pressure in subjects diagnosed with hypertension and/or diabetes in
comparison with healthy controls.
Methods: Voluntary periodic health examinations (PHE) of the citizens have been carried out by the city of
Tampere, Finland. Health data, including body mass index (BMI) and blood pressure, were recorded every five years,
starting at the age of 35 (baseline). A total of 339 subjects from the 50-year-old cohort having hypertension and/or
diabetes were chosen to the study group. The control group included 604 subjects from the 50-year-old cohort
who had the same follow-up information but were not diagnosed with hypertension and/or diabetes.
Results: In the study group the mean BMI had increased from 26.1 at baseline to 28.5 at the final 15-year follow-up
examination. The corresponding increase in the control group was from 23.8 at baseline to 25.5 at the final
follow-up. The difference in change with time between the groups was statistically significant (p = 0.04). On the
average, the controls gained 4.9 kilograms, whereas subjects in the study group gained 7.0 kilograms over the
15 years of follow-up. Systolic and diastolic blood pressures were also higher in the study group already at baseline
and systolic blood pressure increased with time more in the study group than in the control group (p = 0.004).
Conclusions: BMI and blood pressure were higher in the study group in comparison with the controls already at
baseline at 35 years, and the differences were not favorably changed during the follow-up. Apparently, the effect of
PHE had not been as efficient as planned on subjects in the study group, who were already slightly overweight at
baseline.
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Periodic health examinations (PHE) are endorsed as a
means of preventive medicine and usually include med-
ical history, physical examination and multiple screening
using simple laboratory tests. Goals of PHE are early
diagnosis of chronic diseases and the improving of pa-
tient understanding of health and disease [1].
PHE has been a fundamental part of medical practice
for decades despite a lack of consensus on its value. In
Canada, the roots of the annual PHE date back to 1861.
In the 1970s and 1980s, both the Canadian Task Force
on the Periodic Health Examination and the United
States Preventive Services Task Force recommended
abandoning the PHE in favor of regular appropriate
evidence-based preventive care during regular visits
[2,3]. A recent systematic review of medical databases
suggests that the PHE may lessen patient worry, but
other outcomes were vague [4]. It is clear that additional
research is needed to assess the costs, benefits and
harms as well as long-term outcomes, of the PHE [5].
Obesity is a significant risk factor for chronic diseases,
such as hypertension and diabetes [6-8]. More than 50%
of European adults are obese or overweight [9]. We eval-
uated changes in body mass index (BMI) and blood
pressure during 15 years of PHE follow-up. Subjects
diagnosed with hypertension and/or diabetes by the age
of 50 were compared with controls.Methods
The Tampere adult population cardiovascular risk study
(TAMRISK) is a prospective, longitudinal population
based health survey study in Tampere, a city in southern
Finland with a population of 210 000 [10,11].
The Tampere city health care centre has provided
regular PHEs, for screening and counselling, for the
adult population of the city since 1980. All 40- and 50-
year-old inhabitants have been invited to participate in
these health surveys. During some periods, also 35- and
45-year-olds have been invited to participate. The PHE
consisted of one 60-minute session with a public health
nurse at the centre's health examination unit. In the ses-
sion, the questionnaire information and screening tests
were reviewed. Counseling was given on topics selected
by the participant and also on findings of the screening
tests.
Information is available for some participants for
15 years of consecutive 5-year follow-ups concerning
risk factors for cardiovascular diseases, including family
history, blood pressure, lipid values, smoking, waist cir-
cumference, diabetes exercise and eating habits. Also
data on diseases has been recorded. Presently, invitations
for the survey are sent to all subjects from Tampere that
are 40 or 50 years old that year.All subjects who had a self-reported diagnosis of
hypertension and/or diabetes (made by a physician,
n = 681) were chosen from a PHE 50-year-old cohort
(n = 6000). Those subjects who also had information on
35-, 40-, and 45- year PHE formed the study group
(n = 339). The control group included subjects from the
same 50-year-old cohort who were apparently healthy,
and had the same follow-up information. Controls were
chosen for every subject in the study group by matching
them according to sex (n = 604). Baseline clinical exami-
nations had taken place during the calendar year when
the subject caught the age of 35 in 1988–91. At the age
of 40 the same subjects were invited to health examin-
ation again if they still lived in Tampere. This happened
in 1993–96. The third follow up took place in 1998–
2001 at the age of 45. The last follow up was in years
2003–06 at the age of 50. The follow-up time was
15 years. The Ethics Committees of the Tampere Univer-
sity Hospital and the City of Tampere approved the
study. Written informed consent for participation in the
study was obtained from all participants.
Baseline measurements
The basic evaluation in 1988–91 included an interview
by a public health nurse. The interview was conducted
using a structured questionnaire about health and
health-related behavior, including questions about
current and previous diseases. Information on current
and previous diseases was based on self-report of diag-
nosis by a physician, including history of MI and dia-
betes. The questionnaire also assessed symptoms and
ailments experienced within the past six months. These
included questions of health in general and mental
health. Questions of health-related behavior included
current and past smoking. The frequency of physical ex-
ercise comprised both leisure and commute related ac-
tivity. Quantitative estimation of the alcohol intake was
carried out by using three structured questions to deter-
mine the amount and frequency of drinking. The total
mean consumption of all alcoholic drinks was used,
expressed as grams of pure ethanol per week. Physical
examination included a single blood pressure (BP) meas-
urement (mm of mercury) using a calibrated mercury
sphygmomanometer. Serum total cholesterol (mmoles/
liter) was measured by enzymatic techniques. Height
(cm) and weight (kg) were recorded from which the
body mass index was calculated.
Statistical analyses
The description of data was made by means and standard
deviations for continuous variables and by proportions
for categorical variables. The descriptions were con-
structed separately to the study group and controls. The
differences in dichotomous variables were compared with
Kunnas et al. BMC Public Health 2012, 12:654 Page 3 of 5
http://www.biomedcentral.com/1471-2458/12/654Fisher's exact test, in other categorical variables with
Chi-square test and in continuous variables with t-test,
or Mann Whitney U test if the distribution was skewed.
The analysis of variance for repeated measures was used
to assess the differences in changes of body mass index
and blood pressure between the study group and the
control group during the follow up time. Normality of
the distributions of the dependent variables were tested
using Kolmogorov-Smirnov test, and logarithmic trans-
formation was applied if the distribution of the variable
was skewed. The changes were calculated in relation to
the baseline measurement at the age of 40, 45 and 50.
The model included the main effects of group factor and
time, and their interaction. The baseline measurement
of dependent variable was included in the model as a
covariate. The risk level in the analyses was set equal to
p-value of 0.05. Analyses were made using SPSS for
Windows (version 16.0) program.
Results
The characteristics of the 339 cases belonging to the
now 50-year-old study group with diagnosed hyperten-
sion (91%), diabetes (15%) or both (9%), and their 604
controls are shown in Table 1 at baseline, when they
were 35 years old. At the age of 35, subjects in the study
group had already higher mean BMI, systolic andTable 1 Background characteristics of subjects examined
at baseline in 1988–91 at the age of 35 stratified by
whether or not they had hypertension or diabetes (as





Male gender (%) 62 61 0.726
Married (%) 82 83 0.647
In working life (%) 96 93 0.207
Physical exercise at least
3 times/week (%)
25 28 0.442
Current daily smokers (%) 33 28 0.226





95.3 (96.2) 79.2 (90.0) 0.047
Height (cm), mean (SD) 172.8 (9.5) 172.8 (9.2) 0.910
BMI (kg/m2), mean (SD) 26.1 (4.4) 23.8 (3.2) <0.001
Diastolic BP (mm Hg), mean (SD) 86 (10) 78 (8) <0.001
Systolic BP (mm Hg), mean (SD) 135 (13) 124 (10) <0.001
Hypertension (%) 9 0 <0.001
Diabetes (%) 2 0 0.016
Serum cholesterol (mmol/l),
mean (SD)
5.5 (1.0) 5.2 (1.0) 0.001
*Fisher’s test for categorized variables, Mann Whitney U test for continuous
variables. BP, blood pressure; BMI, body mass index.diastolic blood pressure and serum cholesterol as com-
pared to controls. Physical exercise and daily smoking
did not differ between the groups at the age of 35 or
during the whole follow-up. In the study group the self-
reported health status was poorer and more alcohol was
used per week compared to controls at the age of 35.
This difference persisted also at the age of 50 (data not
shown). In the study group there were already 9 subjects
with diagnosed hypertension and two with diabetes at
the age of 35. Subsequently, the mean BMI increased
from 26.1 at baseline to 28.5 at the last follow-up exam-
ination in the study group, whereas in the 604 controls
the corresponding increase was from 23.8 at baseline to
25.5 at the last follow-up. On average, controls gained
4.9 kilograms, whereas subjects with hypertension or
diabetes at the age of 50 gained 7.0 kilograms over the
15 years of follow-up.
The mean changes in BMI and blood pressure are
shown in Table 2. We found a statistically significant
interaction in the change of BMI between the study
group and the control group, and the follow-up time
(p = 0.04). The BMI increased more in the study group
than in the control group, and the increase rate was con-
stant over the follow-up time. In the control group BMI
also increased, but the increase rate was lower especially
during the last 5 years of the follow-up (Figure 1).
A statistically significant interaction was found in the
change of systolic blood pressure between the study
group and the controls, and the follow-up time
(p = 0.004). The increase was slightly higher in the study
group than in the control group. In the study group the
highest increase was found between 40 and 45 years of
age, whereas in the control group the increase rate was
at the highest between the age of 45 and 50.
The diastolic blood pressure remained higher in the
study group than in the control group during the follow-
up time, but the interaction in the change between the
group and the time effects was not statistically signifi-
cant (p = 0.06). At the age of 50, a total of 61% of the
study group were on self-reported blood pressure
medication.
Discussion
A difference was found in the change of BMI between
the study group and the control group during the
follow-up time. In the study group the increase rate was
higher and it was constant over the follow-up time,
whereas in the control group the rate slowed slightly
during the last 5 years of the follow-up. This suggests
that the effects of the PHE had not been efficient enough
to stop the weight gain in either group. Especially in the
study group the remarkable increase in BMI was seen
despite the PHE conducted during the follow-up time
and there were no signals of weight gain slowing down.
Table 2 The change in body mass index (BMI) and blood pressure in subjects from the TAMRISK study stratified by
whether or not they had hypertension or diabetes by the age of 50
Study
group
Controls P-value (interaction in
change between





Change in BMI (kg/m2) 0.04
40 years of age 0.9 (2.3) 0.4 (1.8) 0.43 (0.14;0.72) 0.008
45 years of age 1.8 (2.4) 1.3 (1.8) 0.59 (0.30;0.87) <0.001
50 years of age 2.4 (3.1) 1.7 (2.2) 0.73 (0.36;1.11) <0.001
Change in systolic blood pressure (mmHg) 0.004
40 years of age 2.5 (10.5) 0.6 (8.2) 1.95 (0.54;3.36) 0.007
45 years of age 6.2 (15.5) 2.2 (10.7) 3.99 (1.96;6.03) <0.001
50 years of age 6.2 (20.4) 5.3 (14.1) 0.90 (−1.73;3.53) 0.501
Change in diastolic blood pressure (mmHg) 0.06
40 years of age 2.6 (10.0) 1.4 (7.1) 1.17 (−0.14;2.48) 0.080
45 years of age 4.5 (11.6) 2.4 (7.4) 2.08 (0.58;3.57) 0.007
50 years of age 5.6 (14.0) 5.7 (9.2) −0.16 (−1.95;1.63) 0.859
The change was calculated in relation to baseline (at 35 years of age) during the 15-year follow-up when the periodic health examinations were conducted.
Positive values reflect the increase in BMI or blood pressure. Values are means (standard deviations).
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BMI at baseline. Because obesity in known to be a major
risk factor for cardiovascular disease and diabetes, the
subjects in the study group were in greater risk already
on that basis compared with the control group at the
very beginning. In that sense it would have been possible
to allocate the preventive actions to these subjects in the
PHEs. The result suggests that PHE could not intervene
with the weight gain of subjects who had a high risk to
cardiovascular disease and diabetes.
The increase in blood pressure was in high extent con-
sistent with that of BMI. The blood pressure (both sys-
tolic and diastolic) was at higher level in the study group
than in the control group already at baseline. TheFigure 1 The development of body mass index (BMI) in the
study group and controls during the time the periodic health
examinations were conducted.increase in systolic blood pressure was also greater in
the study group than in the control group between the
ages of 40 and 45. Favorable effects of PHE were not
seen in relation to changes in blood pressure, even
though blood pressure medication had been started for
more than half of the subjects in the study group.
Participant views of the PHE in Tampere have been
previously examined in 1995, in a 45-year-old cohort
[12]. According to the participants' accounts, the discus-
sions and counseling with a public health nurse had
dealt with living habits and, to a lesser extent, with dis-
eases, symptoms and the prevention of illness. Virtually
all respondents saw the PHE program as beneficial for
everyone. Opinions were divided on its benefits com-
pared with medical help from a physician. Looking at
the present results, the PHE, conducted at 5-year inter-
vals by a public health nurse, had not been very effective
in intervening with living habits, since BMI continued to
increase in the study group, who were already at risk at
the age of 35 years. It has been reported that adults who
were overweight but not obese (i.e., 25.0 ≤BMI ≤ 29.9)
were at significantly increased risk of developing numer-
ous health conditions, such as diabetes, gallstones,
hypertension, heart disease, and stroke [6]. Although the
study group had a diagnosis of diabetes or hypertension
by a physician, their medical intervention was not suffi-
cient in terms of blood pressure medication. Certainly a
larger proportion of cases would have been in need for
more regular intervention and medication.
At the age of 35, subjects in the study group used
more alcohol per week (95 g) than controls (79 g). This
alcohol consumption should be considered in the con-
text that self-reporting of drinking is commonly
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of absolute ethanol in Finland for inhabitants 15 years
and older is 8.4 l per year, corresponding to 162 g per
week [13]. Since physical activity was not different be-
tween the study group and controls, the difference in al-
cohol intake has potential to explain the remarkable
increase of BMI in the study group compared to controls
during the follow-up time.
The strength of present study is the large cohort from
which the data was collected. The data analyzed
included 943 subjects all born in the four year period
1951–54 and followed up for 15 years. Thus there was
no confounding by age. The 15-year follow-up of the co-
hort enables to study trends in health factors. However,
since the study group was restricted to residents of a
large city in Finland poses a challenge to how broadly
one can apply the findings. Because the studied popula-
tion represented only Caucasians, our findings cannot be
generalized to minority groups.
Conclusions
The unfavorable differences in BMI and blood pressure
between the study group, who had hypertension and/or
diabetes at the age of 50, and the controls were seen
already at the 35-year-old PHE and they were not cor-
rected during the 15-year follow-up time when PHE
were conducted. This suggests that the effect of PHE
had not been as favorable as desired among the subjects
in the study group, who were at risk already at the age
of 35.
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